# Rho D Immune Globulin

## Rho \(D\) Immune Globulin \[HyperRHO\]

| 藥物代碼 | IRHO |
| :--- | :--- |
| 適應症 | Prevention of Rh haemolytic disease of the newborn by its administration to the Rho \(D\)-ve mother, within 72 hr after birth of her 1st Rho \(D\)+ve infant or after an abortion. |
| 副作用 | Pain at inj site. Slight temp elevation. Hypersensitivity \(rare\) |
| 禁忌 | Rho \(D\)+ve mother. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | Postpartum prophylaxis Inj 1 vial IM into post-partum mother. Antenatal prophylaxis Inj 1 vial at 28 weeks gestation, followed by 1 more dose within 72 hr postpartum if infant is Rh +ve Threatened abortion at any stage of gestation Inj 1 vial. |
| 肝功能異常 | 無需調整劑量  There are no dosage adjustments provided in the manufacturer’s labeling. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | Available evidence suggests that Rho\(D\) immune globulin administration during pregnancy does not harm the fetus or affect future pregnancies.\(UpToDate\)2021/01/25 |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | Adverse events in the breastfeeding infant have not been observed when administered to women for the suppression of RhD isoimmunization.\(UpToDate\)2021/01/25 |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

